TickerFacts.

NRC Health (NRC): Share Repurchases

Annual figures by period end, from SEC filings.

$20.18M
Year ended 2025-12-31
$18.85M
Trailing 12 months to 2026-06-30
-9.9%
3-year compound annual growth
+28.3%
10-year compound annual growth
$30.95M2009-12-31: $84.0K2010-12-31: $399.0K2015-12-31: $1.67M2021-12-31: $4.14M2022-12-31: $27.62M2023-12-31: $19.10M2024-12-31: $30.95M2025-12-31: $20.18M$20.18M
2009-12-31 Share Repurchases (USD) 2025-12-31
Period endedShare RepurchasesChange YoYSource filing
2025-12-31$20.18M-34.8%2026-03-05, From 2025-01-01
2024-12-31$30.95M+62.0%2026-03-05, From 2024-01-01
2023-12-31$19.10M-30.8%2026-03-05, From 2023-01-01
2022-12-31$27.62M+566.7%2025-03-17, From 2022-01-01
2021-12-31$4.14Mn/a2024-02-27, From 2021-01-01
No annual figure between 2015-12-31 and 2021-12-31.
2015-12-31$1.67Mn/a2018-03-14, From 2015-01-01
No annual figure between 2010-12-31 and 2015-12-31.
2010-12-31$399.0K+375.0%2013-03-01, From 2010-01-01
2009-12-31$84.0Kn/a2012-03-01, From 2009-01-01

Share Repurchases at similar companies

Companies with the same SEC industry code (Services-Commercial Physical & Biological Research), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedShare RepurchasesChange YoY
NRC Health (NRC)2025-12-31$20.18M-34.8%
Medpace Holdings, Inc. (MEDP)2025-12-31$917.39M+440.1%
Charles River Laboratories International, Inc. (CRL)2025-12-27$360.67M+202.6%
Incyte Corp (INCY)2025-12-31$0-100.0%
Icon PLC (ICLR)2025-12-31$750.00M+50.0%
Iqvia Holdings Inc. (IQV)2025-12-31$1.24B-7.9%
IB Acquisition Corp. (IBAC)2025-09-30$106.13Mn/a

Compare NRC, MEDP, CRL, INCY side by side · Screen every company in Services-Commercial Physical & Biological Research ↗